BACKGROUND AND OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage is a recognized risk factor for subsequent endogenous infections. However, the association between MRSA carriage and patient survival in hemodialysis patients has not been established. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In March 2007, this prospective cohort study enrolled 306 outpatients under maintenance hemodialysis from a hospital-based dialysis center in Taiwan. They received two consecutive weekly nasal swab cultures at the beginning of the study. Patients having at least one positive culture of MRSA were defined as MRSA carriers. Subjects were followed up until December 31, 2008. The primary outcome was all-cause mortality. Main secondary outcomes were infection-related mortality and morbidity. RESULTS: We identified 29 MRSA carriers (9.48%) at study entry. After a median of 613 days of follow-up, Kaplan-Meier analysis showed significant survival differences between MRSA carriers and noncarriers (log-rank P = 0.02). Compared with noncarriers, MRSA carriers had a 2.46-fold increased risk of dying from any cause, after adjusting for covariates at the start of follow-up. The adjusted hazard ratios of infection-related mortality and occurrence of subsequent S. aureus infection in carriers were 4.99 and 4.31, respectively. CONCLUSIONS: A major limitation is the relatively small sample size of MRSA carriers. Nevertheless, we demonstrated that there may be an association between MRSA nasal carriage and poor clinical outcomes in an outpatient hemodialysis population. This underscores the need for routine surveillance of MRSA nasal carriage and should alert the physicians of a group at high risk of morbidity and mortality.
BACKGROUND AND OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage is a recognized risk factor for subsequent endogenous infections. However, the association between MRSA carriage and patient survival in hemodialysis patients has not been established. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In March 2007, this prospective cohort study enrolled 306 outpatients under maintenance hemodialysis from a hospital-based dialysis center in Taiwan. They received two consecutive weekly nasal swab cultures at the beginning of the study. Patients having at least one positive culture of MRSA were defined as MRSA carriers. Subjects were followed up until December 31, 2008. The primary outcome was all-cause mortality. Main secondary outcomes were infection-related mortality and morbidity. RESULTS: We identified 29 MRSA carriers (9.48%) at study entry. After a median of 613 days of follow-up, Kaplan-Meier analysis showed significant survival differences between MRSA carriers and noncarriers (log-rank P = 0.02). Compared with noncarriers, MRSA carriers had a 2.46-fold increased risk of dying from any cause, after adjusting for covariates at the start of follow-up. The adjusted hazard ratios of infection-related mortality and occurrence of subsequent S. aureus infection in carriers were 4.99 and 4.31, respectively. CONCLUSIONS: A major limitation is the relatively small sample size of MRSA carriers. Nevertheless, we demonstrated that there may be an association between MRSA nasal carriage and poor clinical outcomes in an outpatient hemodialysis population. This underscores the need for routine surveillance of MRSA nasal carriage and should alert the physicians of a group at high risk of morbidity and mortality.
Authors: Carl Suetens; Luc Niclaes; Béatrice Jans; Jan Verhaegen; Annette Schuermans; Johan Van Eldere; Frank Buntinx Journal: J Am Geriatr Soc Date: 2006-12 Impact factor: 5.562
Authors: Shelby D Reed; Joëlle Y Friedman; John J Engemann; Robert I Griffiths; Kevin J Anstrom; Keith S Kaye; Martin E Stryjewski; Lynda A Szczech; L Barth Reller; G Ralph Corey; Kevin A Schulman; Vance G Fowler Journal: Infect Control Hosp Epidemiol Date: 2005-02 Impact factor: 3.254
Authors: Kepler A Davis; Justin J Stewart; Helen K Crouch; Christopher E Florez; Duane R Hospenthal Journal: Clin Infect Dis Date: 2004-08-27 Impact factor: 9.079
Authors: Jan L Nouwen; Alewijn Ott; Marjolein F Q Kluytmans-Vandenbergh; Hélène A M Boelens; Albert Hofman; Alex van Belkum; Henri A Verbrugh Journal: Clin Infect Dis Date: 2004-08-26 Impact factor: 9.079
Authors: Ioannis M Zacharioudakis; Fainareti N Zervou; Panayiotis D Ziakas; Eleftherios Mylonakis Journal: J Am Soc Nephrol Date: 2014-03-20 Impact factor: 10.121
Authors: Heather T Essigmann; Craig L Hanis; Stacia M DeSantis; William B Perkison; David A Aguilar; Goo Jun; D Ashley Robinson; Eric L Brown Journal: Microbiol Spectr Date: 2022-05-18
Authors: Eric L Brown; Jennifer E Below; Rebecca S B Fischer; Heather T Essigmann; Hao Hu; Chad Huff; D Ashley Robinson; Lauren E Petty; David Aguilar; Graeme I Bell; Craig L Hanis Journal: PLoS One Date: 2015-11-16 Impact factor: 3.240